Astellas Pharma discloses TrkA tyrosine kinase inhibitors for the treatment of urinary conditions June 8, 2009
Shanghai Institute Materia Medica claims PPARgamma agonists for polycystic kidney disease June 5, 2009
Pfizer launches Toviaz and YourWay support plan for overactive bladder patients in the U.S. June 4, 2009
Rituximab safe and effective as rescue therapy in idiopathic systemic vasculitis patients May 29, 2009
Phase II study finds Nefecon reduces urine albumin in IgA nephropathy patients / News in Context May 26, 2009
Ark Therapeutics enrolls first patient into phase III study of Trinam in end-stage renal disease May 25, 2009
RSS